|
| MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma |
|
https://doi.org/10.18632/oncotarget.27329
David King, Xiao Dun Li, Gilberto S. Almeida, Colin Kwok, Polly Gravells, Daniel Harrison, Saoirse Burke, Albert Hallsworth, Yann Jamin, Sally George, Simon P. Robinson, Christopher J. Lord, Evon Poon, Daniel Yeomanson, Louis Chesler, Helen E. Bryant
|
| 2141-2159 |
|
| miR-151a enhances Slug dependent angiogenesis |
|
https://doi.org/10.18632/oncotarget.27331
Douglas Jury, Iben Daugaard, Katie J. Sanders, Lise Lotte Hansen, Dritan Agalliu, Irene Munk Pedersen
|
| 2160-2171 |
|
| Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study |
|
https://doi.org/10.18632/oncotarget.27612
Silvia P. Corona, Fabiola Giudici, Guy Jerusalem, Eva Ciruelos, Carla Strina, Marianna Sirico, Ottavia Bernocchi, Manuela Milani, Martina Dester, Nicoletta Ziglioli, Giuseppina Barbieri, Valeria Cervoni, Filippo Montemurro, Daniele Generali
|
| 2172-2181 |
|
| Discovery of fifteen new geroprotective plant extracts and identification of cellular processes they affect to prolong the chronological lifespan of budding yeast |
|
https://doi.org/10.18632/oncotarget.27615
Pamela Dakik, Monica Enith Lozano Rodriguez, Jennifer Anne Baratang Junio, Darya Mitrofanova, Younes Medkour, Tala Tafakori, Tarek Taifour, Vicky Lutchman, Eugenie Samson, Anthony Arlia-Ciommo, Belise Rukundo, Éric Simard, Vladimir I. Titorenko
|
| 2182-2203 |
|
| Tumor microRNA profile and prognostic value for lymph node metastasis in oral squamous cell carcinoma patients |
|
https://doi.org/10.18632/oncotarget.27616
Kelly Yi Ping Liu, Sarah Yuqi Zhu, Denise Brooks, Reanne Bowlby, J. Scott Durham, Yussanne Ma, Richard A. Moore, Andrew J. Mungall, Steven Jones, Catherine F. Poh
|
| 2204-2215 |
|
| Profiling the circulating mRNA transcriptome in human liver disease |
|
https://doi.org/10.18632/oncotarget.27617
Aejaz Sayeed, Brielle E. Dalvano, David E. Kaplan, Usha Viswanathan, John Kulp, Alhaji H. Janneh, Lu-Yu Hwang, Adam Ertel, Cataldo Doria, Timothy Block
|
| 2216-2232 |
|
| Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.27618
Jonathan Canaani, Meital Nagar, Gabriel Heering, Chen Gefen, Ronit Yerushalmi, Noga Shem-Tov, Yulia Volchek, Drorit Merkel, Abraham Avigdor, Avichai Shimoni, Ninette Amariglio, Gidi Rechavi, Arnon Nagler
|
| 2233-2245 |
|
| Exploring the role of survivin in neuroendocrine neoplasms |
|
https://doi.org/10.18632/oncotarget.27631
Ahmad Hanif, Sunyoung Lee, Medhavi Gupta, Ankush Chander, Eric D. Kannisto, Achamaporn Punnanitinont, Robert Fenstermaker, Michael Ciesielski, Kristopher Attwood, Jingxin Qiu, Sai Yendamuri, Renuka Iyer
|
| 2246-2258 |
|
| Correction: Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes |
|
https://doi.org/10.18632/oncotarget.27540
Faruck L. Hakkim, Hamid A. Bakshi, Shabia Khan, Mohamed M. Nasef, Rabia Farzand, Smitha Sam, Luay Rashan, Mohammed S. Al-Baloshi, Sidgi Syed Anwar Abdo Hasson, Ali Al Jabri, Paul A. McCarron, Murtaza M. Tambuwala
|
| 2259-2261 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß